Approval demonstrates significant step forward in the treatment of adult advanced NSCLC patients with METex14
News
ISA Pharmaceuticals announce new trial testing technology for cancers
Trial of Amplivant will begin in a number of cancer patients including those with ovarian cancer
Ampersand Health and UCB partner in new arthritis initiative
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
Cannabis firm launches UK clinic following prescription license allocation
Cantourage has appointed cannabis prescribers and is now officially operational via a new centre
Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies
Engitix and Takeda will extend existing agreement to collaborate extensively in the development of therapeutics in IBD
Novacyt PCR COVID-19 test approved under CTDA legislation
Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products
Catalent acquires Oxfordshire facility to expand biologics in UK and Europe
The biologics development and manufacturing facility is currently under construction near Oxford, UK
NICE overturns previous decision, recommends Merck and Pfizer’s Bavencio
Following successful appeals, the therapy has been recommended for all eligible bladder cancer patients
NICE recommends Koselugo for the treatment of neurofibromatosis type 1
Alexion Pharma UK, AstraZeneca’s Rare Disease group, announces the recommendation of its pivotal neurofibromatosis treatment
UK patients granted early access for radioligand therapy in advanced prostate cancer
Patients with the life-threatening disease are set to benefit from the Early Access to Medicines Scheme
Hundreds of urothelial cancer patients to receive new treatment
NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer
Kynos Therapeutics targets inflammation-driven illness
Spin-off company will focus on developing therapies in areas of inflammation and immunometabolism
Alpha brain waves can predict post-surgery pain
A technique developed by the University of Birmingham demonstrates link between patients’ alpha brain waves and responses to pain
Gilead Sciences opens new drug development hub in Dublin
New Dublin development office will be responsible for paediatric clinical trials for seven products across 18 countries
Novartis presents positive new data on relapsing MS treatment
Data has shown that treatment with Kesimpta is associated with fewer relapses and reduced risk of worsening disability
